Morgan Stanley’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65M | Sell |
|
|||||
|
2025
Q1 | $112M | Sell |
|
|||||
|
2024
Q4 | $136M | Buy |
|
|||||
|
2024
Q3 | $38.8M | Buy |
|
|||||
|
2024
Q2 | $12.2M | Sell |
|
|||||
|
2024
Q1 | $19.2M | Sell |
|
|||||
|
2023
Q4 | $58.1M | Buy |
|
|||||
|
2023
Q3 | $26.2M | Sell |
|
|||||
|
2023
Q2 | $32.3M | Buy |
|
|||||
|
2023
Q1 | $33.6M | Sell |
|
|||||
|
2022
Q4 | $40M | Sell |
|
|||||
|
2022
Q3 | $25.8M | Buy |
|
|||||
|
2022
Q2 | $23.2M | Buy |
|
|||||
|
2022
Q1 | $22.2M | Sell |
|
|||||
|
2021
Q4 | $41.9M | Buy |
|
|||||
|
2021
Q3 | $46.4M | Buy |
|
|||||
|
2021
Q2 | $39.3M | Buy |
|
|||||
|
2021
Q1 | $13M | Sell |
|
|||||
|
2020
Q4 | $15.3M | Sell |
|
|||||
|
2020
Q3 | $18.5M | Buy |
|
|||||
|
2020
Q2 | $11M | Buy |
|
|||||
|
2020
Q1 | $2.37M | Buy |
|
|||||
|
2019
Q4 | $1.7M | Buy |
|
|||||
|
2019
Q3 | $1.01M | Sell |
|
|||||
|
2019
Q2 | $10.5M | Sell |
|
|||||
|
2019
Q1 | $25.8M | Sell |
|
|||||
|
2018
Q4 | $44.6M | Sell |
|
|||||
|
2018
Q3 | $60.6M | Sell |
|
|||||
|
2018
Q2 | $76.9M | Buy |
|
|||||
|
2018
Q1 | $60.2M | Sell |
|
|||||
|
2017
Q4 | $37.8M | Buy |
|
|||||
|
2017
Q3 | $20.7M | Buy |
|
|||||
|
2017
Q2 | $135K | Sell |
|
|||||
|
2017
Q1 | $212K | Buy |
|
|||||
|
2016
Q4 | $111K | Buy |
|
|||||
|
2016
Q3 | $73K | Sell |
|
|||||
|
2016
Q2 | $75K | Sell |
|
|||||
|
2016
Q1 | $248K | Buy |
|